Current Status of Primary, Secondary, and Tertiary Prevention of Coronary Artery Disease
- PMID: 34776817
- PMCID: PMC8580611
- DOI: 10.1055/s-0041-1731273
Current Status of Primary, Secondary, and Tertiary Prevention of Coronary Artery Disease
Abstract
Fifty percent of all death from cardiovascular diseases is due to coronary artery disease (CAD). This is avoidable if early identification is made. Preventive health care has a major role in the fight against CAD. Atherosclerosis and atherosclerotic plaque rupture are involved in the development of CAD. Modifiable risk factors for CAD are dyslipidemia, diabetes, hypertension, cigarette smoking, obesity, chronic renal disease, chronic infection, high C-reactive protein, and hyperhomocysteinemia. CAD can be prevented by modification of risk factors. This paper defines the primary, secondary, and tertiary prevention of CAD. It discusses the mechanism of risk factor-induced atherosclerosis. This paper describes the CAD risk score and its use in the selection of individuals for primary prevention of CAD. Guidelines for primary, secondary, and tertiary prevention of CAD have been described. Modification of risk factors and use of guidelines for prevention of CAD would prevent, regress, and slow down the progression of CAD, improve the quality of life of patient, and reduce the health care cost.
Keywords: atherosclerosis; coronary artery disease; guidelines for prevention; modifiable risk factors of CAD; primary prevention; quality of life; secondary prevention; tertiary prevention.
International College of Angiology. This article is published by Thieme.
Conflict of interest statement
Conflict of Interest None declared.
Similar articles
-
Plaque surface irregularity and calcification length within carotid plaque predict secondary events in patients with coronary artery disease.Atherosclerosis. 2017 Jan;256:29-34. doi: 10.1016/j.atherosclerosis.2016.11.008. Epub 2016 Nov 9. Atherosclerosis. 2017. PMID: 27998824
-
Integrating a Polygenic Risk Score for Coronary Artery Disease as a Risk-Enhancing Factor in the Pooled Cohort Equation: A Cost-Effectiveness Analysis Study.J Am Heart Assoc. 2022 Jun 21;11(12):e025236. doi: 10.1161/JAHA.121.025236. Epub 2022 Jun 14. J Am Heart Assoc. 2022. PMID: 35699184 Free PMC article.
-
Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.J Physiol Pharmacol. 2001 Aug;52(1 Suppl 1):3-31. J Physiol Pharmacol. 2001. PMID: 11795863 Clinical Trial.
-
API expert consensus document on management of ischemic heart disease.J Assoc Physicians India. 2006 Jun;54:469-80. J Assoc Physicians India. 2006. PMID: 16909697 Review.
-
Secondary prevention of coronary artery disease with antimicrobials: current status and future directions.Am J Cardiovasc Drugs. 2002;2(2):107-18. doi: 10.2165/00129784-200202020-00004. Am J Cardiovasc Drugs. 2002. PMID: 14727986 Review.
Cited by
-
Contributions of Pathobiological and Translational Science to Understanding and Managing Ischemic Heart Disease: Progress, Impediments, and Future Directions.Tex Heart Inst J. 2025 Jul 21;52(2):e258609. doi: 10.145403/THIJ-25-8609. eCollection 2025 Jul-Dec. Tex Heart Inst J. 2025. PMID: 40692587 Free PMC article. Review.
-
The Impact of Cardiac Telerehabilitation on Health-Related Quality of Life in Patients Undergoing Percutaneous Coronary Intervention (PCI): A Systematic Review Protocol.Nurs Rep. 2024 Dec 13;14(4):3984-3992. doi: 10.3390/nursrep14040291. Nurs Rep. 2024. PMID: 39728652 Free PMC article.
-
Association between blood phosphorus level and adverse outcomes in patients with coronary artery disease: A meta-analysis.Heliyon. 2024 Sep 26;10(19):e38565. doi: 10.1016/j.heliyon.2024.e38565. eCollection 2024 Oct 15. Heliyon. 2024. PMID: 39397948 Free PMC article.
-
Do the Gender and the Number of Comorbidities and the Use of Tertiary Prevention Play a Role in the Severity of Anxiety and Depression in Patients with Coronary Artery Disease? A POLASPIRE II Study.J Clin Med. 2024 Jun 28;13(13):3812. doi: 10.3390/jcm13133812. J Clin Med. 2024. PMID: 38999377 Free PMC article.
-
Differences in severity of diffuse and focal coronary stenosis between visual and quantitative assessment.Front Cardiovasc Med. 2024 Dec 16;11:1501576. doi: 10.3389/fcvm.2024.1501576. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39736881 Free PMC article.
References
-
- Wong N D. Epidemiological studies of CHD and the evolution of preventive cardiology. Nat Rev Cardiol. 2014;11(05):276–289. - PubMed
-
- Huma S, Tariq R, Amin D F, Mahmood D KT.Modifiable and non-modifiable predisposing risk factors of myocardial infarctionReview2012
-
- World Health Organization The World Health Report 2002 Reducing risks, promoting healthy lifeAccessed May 25, 2021 at:https://apps.who.int/iris/bitstream/handle/10665/42510/WHR_2002.pdf?sequ...
-
- Prasad K. Reduction of serum cholesterol and hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed. Circulation. 1999;99(10):1355–1362. - PubMed
-
- Kannel W B, McGee D L. Diabetes and cardiovascular disease. The Framingham study. JAMA. 1979;241(19):2035–2038. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous